|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3060229 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14855343.1 |
| Date of filing the European patent application | 2014-10-23 | |
| (97) | Date of publication of the European application | 2016-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (86) | Number | PCT/US2014/061997 |
| Date | 2014-10-23 |
| (87) | Number | WO 2015/061584 |
| Date | 2015-04-30 |
| (30) | Number | Date | Country code |
| 201361895143 P | 2013-10-24 | US |
| (72) |
LEACH, William , US
LEWUS, Rachael , US
MCGIVNEY, James , US
NEWELL, Kelcy , US
STEWART, Kevin Douglas , US
|
| (73) |
AstraZeneca AB ,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilios vandeninės antikūno vaistinės formos |
| STABLE, AQUEOUS ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 12 | 289.00 EUR |
| 2026-10-23 |